A phase I/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy (HAART) in HIV-positive patients with cancer: AIDS Malignancy Consortium Trial AMC 061

BACKGROUND: Treatment of non-AIDS defining cancers (NADCs) may be complicated by drug interactions between highly active antiretroviral therapy (HAART) and chemotherapy. This trial is the first by the AIDS Malignancy Consortium assessing targeted therapies and HAART in HIV+ cancer patients (Clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rudek, Michelle A, Moore, Page C., Mitsuyasu, Ronald T., Dezube, Bruce J., Aboulafia, David, Gerecitano, John, Sullivan, Ryan, Cianfrocca, Mary E., Henry, David H., Ratner, Lee, Haigentz, Missak, Dowlati, Afshin, Little, Richard F., Ivy, S. Percy, Deeken, John F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038645/
https://ncbi.nlm.nih.gov/pubmed/24474568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28554
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky